CYCLACEL PHARMACEUTICALS INC's ticker is CYCC and the CUSIP is 23254L603.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,275 | -39.9% | 3,591 | -0.4% | 0.00% | – |
| Q2 2023 | $2,123 | +106050.0% | 3,605 | -1.0% | 0.00% | – |
| Q1 2023 | $2 | +100.0% | 3,641 | +63.0% | 0.00% | – |
| Q4 2022 | $1 | -99.9% | 2,234 | +156.5% | 0.00% | – |
| Q3 2022 | $1,000 | -83.3% | 871 | -84.0% | 0.00% | – |
| Q2 2022 | $6,000 | -40.0% | 5,442 | +62.1% | 0.00% | – |
| Q1 2022 | $10,000 | +900.0% | 3,358 | +1579.0% | 0.00% | – |
| Q4 2021 | $1,000 | 0.0% | 200 | -14.2% | 0.00% | – |
| Q2 2021 | $1,000 | -75.0% | 233 | -62.7% | 0.00% | – |
| Q1 2021 | $4,000 | +300.0% | 624 | +670.4% | 0.00% | – |
| Q4 2020 | $1,000 | – | 81 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SPHERA FUNDS MANAGEMENT LTD. | 250,000 | $365,000 | 0.05% |
| McIlrath & Eck, LLC | 26,342 | $38,000 | 0.01% |
| Schonfeld Strategic Advisors LLC | 615,200 | $898,000 | 0.01% |
| ACADIAN ASSET MANAGEMENT LLC | 367,477 | $535,000 | 0.00% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 12,800 | $19,000 | 0.00% |
| Point72 Asset Management, L.P. | 230,000 | $336,000 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 61,816 | $90,000 | 0.00% |
| STATE STREET CORP | 10,510 | $15,000 | 0.00% |
| MILLENNIUM MANAGEMENT LLC | 195,445 | $285,000 | 0.00% |
| MORGAN STANLEY | 1,200 | $2,000 | 0.00% |